Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 130 entries
Sorted by: Best Match Show Resources per page
The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome.

British journal of cancer

D'Arcangelo E, Wu NC, Cadavid JL, McGuigan AP.
PMID: 31992854
Br J Cancer. 2020 Mar;122(7):931-942. doi: 10.1038/s41416-019-0705-1. Epub 2020 Jan 29.

The tumour microenvironment (TME) determines vital aspects of tumour development, such as tumour growth, metastases and response to therapy. Cancer-associated fibroblasts (CAFs) are abundant and extremely influential in this process and interact with cellular and matrix TME constituents such...

Cite
D'Arcangelo E, Wu NC, Cadavid JL, et al. The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome. Br J Cancer. 2020;122(7):931-942doi: 10.1038/s41416-019-0705-1.
D'Arcangelo, E., Wu, N. C., Cadavid, J. L., & McGuigan, A. P. (2020). The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome. British journal of cancer, 122(7), 931-942. https://doi.org/10.1038/s41416-019-0705-1
D'Arcangelo, Elisa, et al. "The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome." British journal of cancer vol. 122,7 (2020): 931-942. doi: https://doi.org/10.1038/s41416-019-0705-1
D'Arcangelo E, Wu NC, Cadavid JL, McGuigan AP. The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome. Br J Cancer. 2020 Mar;122(7):931-942. doi: 10.1038/s41416-019-0705-1. Epub 2020 Jan 29. PMID: 31992854; PMCID: PMC7109057.
Copy Download .nbib Format: NLM
Visceral adiposity and cancer survival: a review of imaging studies.

European journal of cancer care

Xiao J, Mazurak VC, Olobatuyi TA, Caan BJ, Prado CM.
PMID: 27921375
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12611. doi: 10.1111/ecc.12611. Epub 2016 Dec 06.

Although obesity is a well-known risk factor for cancer, the association between obesity and cancer survival remains controversial. This is partially due to the inability of conventional obesity measures to directly assess adiposity or adipose tissue distribution. As a...

Cite
Xiao J, Mazurak VC, Olobatuyi TA, et al. Visceral adiposity and cancer survival: a review of imaging studies. Eur J Cancer Care (Engl). 2016;27(2):e12611doi: 10.1111/ecc.12611.
Xiao, J., Mazurak, V. C., Olobatuyi, T. A., Caan, B. J., & Prado, C. M. (2018). Visceral adiposity and cancer survival: a review of imaging studies. European journal of cancer care, 27(2), e12611. https://doi.org/10.1111/ecc.12611
Xiao, J, et al. "Visceral adiposity and cancer survival: a review of imaging studies." European journal of cancer care vol. 27,2 (2018): e12611. doi: https://doi.org/10.1111/ecc.12611
Xiao J, Mazurak VC, Olobatuyi TA, Caan BJ, Prado CM. Visceral adiposity and cancer survival: a review of imaging studies. Eur J Cancer Care (Engl). 2018 Mar;27(2):e12611. doi: 10.1111/ecc.12611. Epub 2016 Dec 06. PMID: 27921375.
Copy Download .nbib Format: NLM
Drug management of pain in cancer patients.

Canadian Medical Association journal

Appel WC.
PMID: 3978510
Can Med Assoc J. 1985 Apr 15;132(8):899-900.
Free PMC Article

No abstract available.

Cite
Appel WC. Drug management of pain in cancer patients. Can Med Assoc J. 1985;132(8):899-900
Appel, W. C. (1985). Drug management of pain in cancer patients. Canadian Medical Association journal, 132(8), 899-900.
Appel, W C. "Drug management of pain in cancer patients." Canadian Medical Association journal vol. 132,8 (1985): 899-900.
Appel WC. Drug management of pain in cancer patients. Can Med Assoc J. 1985 Apr 15;132(8):899-900. PMID: 3978510; PMCID: PMC1345891.
Copy Download .nbib Format: NLM
[Psychooncological Care: A Challenge].

Deutsche medizinische Wochenschrift (1946)

Mehnert A, Koranyi S.
PMID: 29506298
Dtsch Med Wochenschr. 2018 Mar;143(5):316-323. doi: 10.1055/s-0043-107631. Epub 2018 Mar 05.

Cancer patients and their relatives suffer from multiple psychological and social problems associated with the illness itself and its treatment. The major challenge for an excellent psychooncological support is the further development and nationwide implementation of effective, patient-centered, quality...

Cite
Mehnert A, Koranyi S. Psychoonkologische Versorgung: eine Herausforderung. [Psychooncological Care: A Challenge]. Dtsch Med Wochenschr. 2018;143(5):316-323doi: 10.1055/s-0043-107631.
Mehnert, A., & Koranyi, S. (2018). Psychoonkologische Versorgung: eine Herausforderung. [Psychooncological Care: A Challenge]. Deutsche medizinische Wochenschrift (1946), 143(5), 316-323. https://doi.org/10.1055/s-0043-107631
Mehnert, Anja, and Koranyi, Susan. "Psychoonkologische Versorgung: eine Herausforderung." [Psychooncological Care: A Challenge]. Deutsche medizinische Wochenschrift (1946) vol. 143,5 (2018): 316-323. doi: https://doi.org/10.1055/s-0043-107631
Mehnert A, Koranyi S. Psychoonkologische Versorgung: eine Herausforderung. [Psychooncological Care: A Challenge]. Dtsch Med Wochenschr. 2018 Mar;143(5):316-323. doi: 10.1055/s-0043-107631. Epub 2018 Mar 05. German. PMID: 29506298.
Copy Download .nbib Format: NLM
Cancer and Venous Thromboembolic Disease: A Review.

The oncologist

Donnellan E, Khorana AA.
PMID: 28174293
Oncologist. 2017 Feb;22(2):199-207. doi: 10.1634/theoncologist.2016-0214. Epub 2017 Feb 07.

Venous thromboembolism (VTE), including deep-vein thrombosis and pulmonary embolism, represents a major cause of morbidity and mortality in cancer patients. Patients with cancer are six times more likely to develop VTE than their noncancer counterparts, and VTE is the...

Cite
Donnellan E, Khorana AA. Cancer and Venous Thromboembolic Disease: A Review. Oncologist. 2017;22(2):199-207doi: 10.1634/theoncologist.2016-0214.
Donnellan, E., & Khorana, A. A. (2017). Cancer and Venous Thromboembolic Disease: A Review. The oncologist, 22(2), 199-207. https://doi.org/10.1634/theoncologist.2016-0214
Donnellan, Eoin, and Khorana, Alok A. "Cancer and Venous Thromboembolic Disease: A Review." The oncologist vol. 22,2 (2017): 199-207. doi: https://doi.org/10.1634/theoncologist.2016-0214
Donnellan E, Khorana AA. Cancer and Venous Thromboembolic Disease: A Review. Oncologist. 2017 Feb;22(2):199-207. doi: 10.1634/theoncologist.2016-0214. Epub 2017 Feb 07. PMID: 28174293; PMCID: PMC5330704.
Copy Download .nbib Format: NLM
Untreated Depression Common in Caregiving Spouses of Patients With Cancer.

Cancer

[No authors listed]
PMID: 30117599
Cancer. 2018 Aug 01;124(15):3078-3079. doi: 10.1002/cncr.31654.

No abstract available.

Cite
Untreated Depression Common in Caregiving Spouses of Patients With Cancer. Cancer. 2018;124(15):3078-3079doi: 10.1002/cncr.31654.
(2018). Untreated Depression Common in Caregiving Spouses of Patients With Cancer. Cancer, 124(15), 3078-3079. https://doi.org/10.1002/cncr.31654
"Untreated Depression Common in Caregiving Spouses of Patients With Cancer." Cancer vol. 124,15 (2018): 3078-3079. doi: https://doi.org/10.1002/cncr.31654
Untreated Depression Common in Caregiving Spouses of Patients With Cancer. Cancer. 2018 Aug 01;124(15):3078-3079. doi: 10.1002/cncr.31654. PMID: 30117599.
Copy Download .nbib Format: NLM
Trials and Tribulations of Corrected QT Interval Monitoring in Oncology: Rationale for a Practice-Changing Standardized Approach.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Muluneh B, Richardson DR, Hicks C, Jensen BC, Zeidner JF.
PMID: 31310577
J Clin Oncol. 2019 Oct 20;37(30):2719-2721. doi: 10.1200/JCO.19.00922.

No abstract available.

Cite
Muluneh B, Richardson DR, Hicks C, et al. Trials and Tribulations of Corrected QT Interval Monitoring in Oncology: Rationale for a Practice-Changing Standardized Approach. J Clin Oncol. 2019;37(30):2719-2721doi: 10.1200/JCO.19.00922.
Muluneh, B., Richardson, D. R., Hicks, C., Jensen, B. C., & Zeidner, J. F. (2019). Trials and Tribulations of Corrected QT Interval Monitoring in Oncology: Rationale for a Practice-Changing Standardized Approach. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37(30), 2719-2721. https://doi.org/10.1200/JCO.19.00922
Muluneh, Benyam, et al. "Trials and Tribulations of Corrected QT Interval Monitoring in Oncology: Rationale for a Practice-Changing Standardized Approach." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 37,30 (2019): 2719-2721. doi: https://doi.org/10.1200/JCO.19.00922
Muluneh B, Richardson DR, Hicks C, Jensen BC, Zeidner JF. Trials and Tribulations of Corrected QT Interval Monitoring in Oncology: Rationale for a Practice-Changing Standardized Approach. J Clin Oncol. 2019 Oct 20;37(30):2719-2721. doi: 10.1200/JCO.19.00922. PMID: 31310577.
Copy Download .nbib Format: NLM
The circadian clock in cancer development and therapy.

Progress in molecular biology and translational science

Fu L, Kettner NM.
PMID: 23899600
Prog Mol Biol Transl Sci. 2013;119:221-82. doi: 10.1016/B978-0-12-396971-2.00009-9.

Most aspects of mammalian function display circadian rhythms driven by an endogenous clock. The circadian clock is operated by genes and comprises a central clock in the brain that responds to environmental cues and controls subordinate clocks in peripheral...

Cite
Fu L, Kettner NM. The circadian clock in cancer development and therapy. Prog Mol Biol Transl Sci. 2013;119:221-82doi: 10.1016/B978-0-12-396971-2.00009-9.
Fu, L., & Kettner, N. M. (2013). The circadian clock in cancer development and therapy. Progress in molecular biology and translational science, 119221-82. https://doi.org/10.1016/B978-0-12-396971-2.00009-9
Fu, Loning, and Kettner, Nicole M. "The circadian clock in cancer development and therapy." Progress in molecular biology and translational science vol. 119 (2013): 221-82. doi: https://doi.org/10.1016/B978-0-12-396971-2.00009-9
Fu L, Kettner NM. The circadian clock in cancer development and therapy. Prog Mol Biol Transl Sci. 2013;119:221-82. doi: 10.1016/B978-0-12-396971-2.00009-9. PMID: 23899600; PMCID: PMC4103166.
Copy Download .nbib Format: NLM
Interstitial fluid flow and drug delivery in vascularized tumors: a computational model.

PloS one

Welter M, Rieger H.
PMID: 23940570
PLoS One. 2013 Aug 05;8(8):e70395. doi: 10.1371/journal.pone.0070395. Print 2013.

Interstitial fluid is a solution that bathes and surrounds the human cells and provides them with nutrients and a way of waste removal. It is generally believed that elevated tumor interstitial fluid pressure (IFP) is partly responsible for the...

Cite
Welter M, Rieger H. Interstitial fluid flow and drug delivery in vascularized tumors: a computational model. PLoS One. 2013;8(8):e70395doi: 10.1371/journal.pone.0070395.
Welter, M., & Rieger, H. (2013). Interstitial fluid flow and drug delivery in vascularized tumors: a computational model. PloS one, 8(8), e70395. https://doi.org/10.1371/journal.pone.0070395
Welter, Michael, and Rieger, Heiko. "Interstitial fluid flow and drug delivery in vascularized tumors: a computational model." PloS one vol. 8,8 (2013): e70395. doi: https://doi.org/10.1371/journal.pone.0070395
Welter M, Rieger H. Interstitial fluid flow and drug delivery in vascularized tumors: a computational model. PLoS One. 2013 Aug 05;8(8):e70395. doi: 10.1371/journal.pone.0070395. Print 2013. PMID: 23940570; PMCID: PMC3734291.
Copy Download .nbib Format: NLM
Eat dessert first.

Clinical journal of oncology nursing

Mayer DK.
PMID: 21112843
Clin J Oncol Nurs. 2010 Dec;14(6):677. doi: 10.1188/10.CJON.677.

No abstract available.

Cite
Mayer DK. Eat dessert first. Clin J Oncol Nurs. 2010;14(6):677doi: 10.1188/10.CJON.677.
Mayer, D. K. (2010). Eat dessert first. Clinical journal of oncology nursing, 14(6), 677. https://doi.org/10.1188/10.CJON.677
Mayer, Deborah K. "Eat dessert first." Clinical journal of oncology nursing vol. 14,6 (2010): 677. doi: https://doi.org/10.1188/10.CJON.677
Mayer DK. Eat dessert first. Clin J Oncol Nurs. 2010 Dec;14(6):677. doi: 10.1188/10.CJON.677. PMID: 21112843.
Copy Download .nbib Format: NLM
Spiritual needs of patients with chronic pain diseases and cancer - validation of the spiritual needs questionnaire.

European journal of medical research

Büssing A, Balzat HJ, Heusser P.
PMID: 20696636
Eur J Med Res. 2010 Jun 28;15(6):266-73. doi: 10.1186/2047-783x-15-6-266.

PURPOSE: For many patients confronted with chronic diseases, spirituality/religiosity is a relevant resource to cope. While most studies on patients' spiritual needs refer to the care of patients at the end of life, our intention was to develop an...

Cite
Büssing A, Balzat HJ, Heusser P. Spiritual needs of patients with chronic pain diseases and cancer - validation of the spiritual needs questionnaire. Eur J Med Res. 2010;15(6):266-73doi: 10.1186/2047-783x-15-6-266.
Büssing, A., Balzat, H. J., & Heusser, P. (2010). Spiritual needs of patients with chronic pain diseases and cancer - validation of the spiritual needs questionnaire. European journal of medical research, 15(6), 266-73. https://doi.org/10.1186/2047-783x-15-6-266
Büssing, A, et al. "Spiritual needs of patients with chronic pain diseases and cancer - validation of the spiritual needs questionnaire." European journal of medical research vol. 15,6 (2010): 266-73. doi: https://doi.org/10.1186/2047-783x-15-6-266
Büssing A, Balzat HJ, Heusser P. Spiritual needs of patients with chronic pain diseases and cancer - validation of the spiritual needs questionnaire. Eur J Med Res. 2010 Jun 28;15(6):266-73. doi: 10.1186/2047-783x-15-6-266. PMID: 20696636; PMCID: PMC3351996.
Copy Download .nbib Format: NLM
[Characteristics of and strategy for cancer pain].

Nihon rinsho. Japanese journal of clinical medicine

Matsuo N.
PMID: 17233410
Nihon Rinsho. 2007 Jan;65(1):17-21.

75% of cancer patients have pain, which can greatly affect their quality of life. In cancer patients, not only physical pain but also total pain must be treated. Cancer pain can be classified as nociceptive pain or neuropathic pain...

Cite
Matsuo N. [Characteristics of and strategy for cancer pain]. Nihon Rinsho. 2007;65(1):17-21
Matsuo, N. (2007). [Characteristics of and strategy for cancer pain]. Nihon rinsho. Japanese journal of clinical medicine, 65(1), 17-21.
Matsuo, Naoki. "[Characteristics of and strategy for cancer pain]." Nihon rinsho. Japanese journal of clinical medicine vol. 65,1 (2007): 17-21.
Matsuo N. [Characteristics of and strategy for cancer pain]. Nihon Rinsho. 2007 Jan;65(1):17-21. Japanese. PMID: 17233410.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 130 entries